SR144528 as inverse agonist of CB2 cannabinoid receptor.

Man Hee Rhee, Sang Keun Kim

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

It is now well established that several G protein- coupled receptors can signal without agonist stimulation (constitutive receptors). Inverse agonists have been shown to inhibit the activity of such constitutive G protein-coupled receptor signaling. Agonist activation of the G(i/o)-coupled peripheral cannabinoid receptor CB2 normally inhibits adenylyl cyclase type V and stimulates adenylyl cyclase type II. Using transfected COS cells, we show here that application of SR144528, an inverse agonist of CB2, leads to a reverse action (stimulation of adenylyl cyclase V and inhibition of adenylyl cyclase II). This inverse agonism of SR144528 is dependent on the temperature, as well as on the concentration of the cDNA of CB2 transfected. Pertussis toxin blocked the regulation of adenylyl cyclase activity by SR 144528.

Original languageEnglish
Pages (from-to)179-184
Number of pages6
JournalJournal of Veterinary Science
Volume3
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Dive into the research topics of 'SR144528 as inverse agonist of CB2 cannabinoid receptor.'. Together they form a unique fingerprint.

Cite this